VYNE Investor Relations Presentation
VYNE-Investor-Presentation
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
VYNE-Investor-Presentation
KOL Event – Novel InhiBET BET Inhibitor Platform
Repibresib Phase 2b Vitiligo ResultsvF.pdf
https://vynetherapeutics.com/wp-content/uploads/2025/07/VYN202-PsO-Phase-1b-Data-Presentation-vF.pdf